Novel therapeutic approaches for progressive renal disorders by targeting glomerular component mesangial and endothelial cells.
Maeshima
Yohei
Y
Department of Medicine and Clinical Science, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Okayama, 700-8558, Japan. ymaeshim@md.okayma-u.ac.jp.
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000818:Animals; D042783:Endothelial Cells / Q000276:immunology / Q000473:pathology*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology*; D050527:Mesangial Cells / Q000276:immunology / Q000473:pathology*
D020533:Angiogenesis Inhibitors